Cornercap Investment Counsel’s Edwards Lifesciences EW Stock Holding History

Cornercap Investment Counsel’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,119	Closed	-$294K	–	604
2023 Q2	$294K	Sell	3,119 -21,446	-87%	-$1.86M	0.05%	464
2023 Q1	$2.03M	Buy	+24,565	New	+$1.93M	0.36%	66
2021 Q3	–	Sell	-5,339	Closed	-$553K	–	563
2021 Q2	$553K	Sell	5,339 -245	-4%	-$23.1K	0.06%	457
2021 Q1	$467K	Buy	+5,584	New	+$472K	0.05%	473
2020 Q4	–	Sell	-8,154	Closed	-$651K	–	498
2020 Q3	$651K	Sell	8,154 -22,841	-74%	-$1.78M	0.09%	343
2020 Q2	$2.14M	Buy	+30,995	New	+$2.2M	0.35%	100

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cornercap Investment Counsel's EW Position: Q3 2023 in Review

Cornercap Investment Counsel sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 3,119 shares — an estimated $294K sold.

Cornercap Investment Counsel first reported a position in EW in Q2 2020 and held it in 6 quarters. The position peaked at $2.14M in Q2 2020. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

Cornercap Investment Counsel reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
Cornercap Investment Counsel sold 3,119 Edwards Lifesciences shares in Q3 2023, an estimated $294K.
Cornercap Investment Counsel first reported a position in Edwards Lifesciences in Q2 2020 and held it in 6 quarters.
Cornercap Investment Counsel's Edwards Lifesciences position peaked at $2.14M in Q2 2020.
1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Cornercap Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.